Nurix Therapeutics, Inc.

Legal & General Group Plc NRIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

84,989

Value ($000)

1,612

Weight

0.0%

2020 Q3 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	1,612	0.0%	84,989	12/31/2025
2025 Q3	11/13/2025	766	0.0%	82,917	9/30/2025
2025 Q2	8/12/2025	711	0.0%	62,420	6/30/2025
2025 Q1	5/15/2025	696	0.0%	58,619	3/31/2025
2024 Q4	2/13/2025	1,138	0.0%	60,417	12/31/2024
2024 Q3	2/28/2025	1,346	0.0%	59,899	9/30/2024
2024 Q2	5/29/2025	1,062	0.0%	50,880	6/30/2024
2024 Q1	5/29/2025	99	0.0%	6,742	3/31/2024
2023 Q4	5/29/2025	71	0.0%	6,896	12/31/2023
2023 Q3	11/14/2023	251	0.0%	31,979	9/30/2023
2023 Q2	8/14/2023	325	0.0%	32,538	6/30/2023
2023 Q1	5/15/2023	130	0.0%	14,606	3/31/2023
2022 Q4	2/14/2023	154	0.0%	13,996	12/31/2022
2022 Q3	11/14/2022	173	0.0%	13,279	9/30/2022
2022 Q2	8/22/2022	154	0.0%	12,173	6/30/2022
2022 Q1	5/16/2022	126	0.0%	8,957	3/31/2022
2021 Q4	2/14/2022	259	0.0%	8,967	12/31/2021
2021 Q3	11/15/2021	267	0.0%	8,914	9/30/2021
2021 Q2	8/12/2021	98	0.0%	3,673	6/30/2021
2021 Q1	5/17/2021	90	0.0%	2,926	3/31/2021
2020 Q4	2/12/2021	55	0.0%	1,678	12/31/2020
2020 Q3	11/13/2020	43	0.0%	1,244	9/30/2020